ProCE Banner Activity

Chronic Myeloid Leukemia: Optimizing Use of TKIs to Individualize Treatment Across the Disease Spectrum

Slideset

Download these slides covering chronic-phase chronic myeloid leukemia treatment, including optimal therapy selection, strategies to optimize treatment-free remission, and overcoming resistance to TKI therapy.

Released: August 12, 2024

Expiration: August 11, 2025

Share

Faculty

Fadi Haddad

Fadi Haddad, MD

Assistant Professor
Leukemia Department
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Novartis Pharmaceuticals Corporation.

Bristol Myers Squibb

Novartis Pharmaceuticals Corporation